"Intermittent Fasting and Cognitive Function: A New Defense Against Dementia? Plus, Turn Bio and HanAll Biopharma Collaborate on Innovative Therapeutic Solutions"

"Intermittent Fasting and Cognitive Function: A New Defense Against Dementia? Plus, Turn Bio and HanAll Biopharma Collaborate on Innovative Therapeutic Solutions"

Released Saturday, 1st June 2024
Good episode? Give it some love!
"Intermittent Fasting and Cognitive Function: A New Defense Against Dementia? Plus, Turn Bio and HanAll Biopharma Collaborate on Innovative Therapeutic Solutions"

"Intermittent Fasting and Cognitive Function: A New Defense Against Dementia? Plus, Turn Bio and HanAll Biopharma Collaborate on Innovative Therapeutic Solutions"

"Intermittent Fasting and Cognitive Function: A New Defense Against Dementia? Plus, Turn Bio and HanAll Biopharma Collaborate on Innovative Therapeutic Solutions"

"Intermittent Fasting and Cognitive Function: A New Defense Against Dementia? Plus, Turn Bio and HanAll Biopharma Collaborate on Innovative Therapeutic Solutions"

Saturday, 1st June 2024
Good episode? Give it some love!
Rate Episode
List

Send us a text

AI News Today is your go-to podcast for the latest information regarding the evolving world of artificial intelligence. This gripping podcast covers areas like machine learning, robotics, and data science, with the primary goal of explaining complex processes in simple terms. In today's episode, we explore intriguing breakthroughs and advancements in the AI sector.The first story discusses how a new study uses AI to understand the benefits of intermittent fasting in improving cognitive function. The AI analysis shows that periodic fasting might stimulate metabolic shifts resulting in improved brain health. However, researchers highlight the need for more detailed research before any definitive claims can be made.Next, we dive into the world of pharmaceutical AI with the partnership between Turn Bio and HanAll Biopharma. This monumental collaboration aims to drive the development of protein therapeutics through the combined powers of AI and bioengineering. Both companies aim to develop better and innovative therapeutic solutions.That's all for today. Stay tuned for another insightful episode tomorrow as we continue to unravel the churning world of AI. Subscribe now to AI News Today to ensure you never miss an update.

Show More